IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival

Abstract

By integrating networks of activated molecular glioma pathways, the model based on genotype better predicts prognosis than histology and, therefore, provides a more reliable tool for standardizing future treatment strategies.